GH:NASDAQ
Guardant Health Inc
165,56 $
arrow_downward
-1,65%(-2,77) 1D
165,56 $
0,00% (0,00)
bedtimeAfter hours
Closed: 8 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
166,24 $
High
167,28 $
Low
161,61 $
Mkt. cap
22,22 մլրդ
Avg. vol.
1,89 մլն
Volume
1,60 մլն
52-wk high
191,01 $
52-wk low
61,00 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
Open
166,24 $
High
167,28 $
Low
161,61 $
Mkt. cap
22,22 մլրդ
Avg. vol.
1,89 մլն
Volume
1,60 մլն
52-wk high
191,01 $
52-wk low
61,00 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Investing.com
·
1 ժամ առաջ
Guardant Health receives European approval for breast cancer test
Stock Titan
·
2 ժամ առաջ
A blood test in Europe can help identify who may benefit from AstraZeneca’s breast cancer drug
Yahoo Finance
·
2 ժամ առաջ
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
Simply Wall Street
·
1 օր առաջ
How Positive Melanoma Test Data Will Impact Guardant Health Stock
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 հզր
Founded2012
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth care provider
Websiteguardanthealth.com